Accepted for Publication: September 12, 2022.
Published Online: September 23, 2022. doi:10.1001/jama.2022.17811
Corresponding Author: Jessica P. Ridgway, MD, Department of Medicine, University of Chicago, 5841 S Maryland Ave, MC 5065, Chicago, IL 60637 (Jessica.ridgway@uchospitals.edu).
Author Contributions: Dr Robicsek had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Ridgway, Tideman, Wright, Diaz, Robicsek.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Ridgway, Tideman, Wright, Robicsek.
Critical revision of the manuscript for important intellectual content: Tideman, French, Wright, Parsons, Diaz, Robicsek.
Statistical analysis: Tideman, French, Wright, Robicsek.
Obtained funding: Robicsek.
Administrative, technical, or material support: Tideman, Parsons, Diaz, Robicsek.
Supervision: Parsons, Robicsek.
Conflict of Interest Disclosures: Dr Ridgway reported receiving personal fees from Gilead Sciences. Dr Diaz reported receiving grants from Gilead, Roche, Regeneron, Edesa Biotech Inc, Boehringer Ingelheim, NeuroBo Pharmaceuticals Inc, and the National Institutes of Health and serving as a scientific board member for Safeology. No other disclosures were reported.